A Randomized Controlled Trial of Spermidine for the Prevention of Radiation-Induced Xerostomia in Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This study is a single-center, double-blind, randomized controlled clinical trial with placebo as the control, aiming to evaluate the effectiveness of spermidine in preventing radiation-induced xerostomia during radiotherapy for head and neck tumors (including nasopharyngeal carcinoma).
Epistemonikos ID: 435f047f584a1e40e61037cbb2acab769d60bd5d
First added on: Jun 26, 2025